Creative Financial Designs’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$676K Buy
11,892
+1,332
+13% +$63.5K 0.03% 345
2026
Q1
$462K Sell
10,560
-1,564
-13% -$72.3K 0.03% 349
2025
Q4
$551K Buy
12,124
+481
+4% +$21.3K 0.03% 317
2025
Q3
$452K Buy
11,643
+6,068
+109% +$220K 0.03% 342
2025
Q2
$188K Buy
5,575
+2,589
+87% +$82K 0.01% 504
2025
Q1
$94.9K Buy
+2,986
New +$113K 0.01% 633
2024
Q3
Sell
-56
Closed -$2.32K 1701
2024
Q2
$2.32K Sell
56
-36
-39% -$1.5K ﹤0.01% 1464
2024
Q1
$4.2K Hold
92
﹤0.01% 1347
2023
Q4
$4.26K Sell
92
-46
-33% -$1.88K ﹤0.01% 1288
2023
Q3
$5.59K Sell
138
-349
-72% -$15.9K ﹤0.01% 1164
2023
Q2
$23.6K Buy
487
+325
+201% +$16.3K ﹤0.01% 809
2023
Q1
$7.98K Hold
162
﹤0.01% 1011
2022
Q4
$8.2K Hold
162
﹤0.01% 939
2022
Q3
$8K Hold
162
﹤0.01% 932
2022
Q2
$8K Sell
162
-4
-2% -$203 ﹤0.01% 905
2022
Q1
$10K Sell
166
-2,775
-94% -$175K ﹤0.01% 900
2021
Q4
$233K Sell
2,941
-1,452
-33% -$122K 0.04% 281
2021
Q3
$389K Buy
+4,393
New +$412K 0.06% 210

Other funds holding GNOM

Creative Financial Designs's GNOM Position: Q2 2026 in Review

Creative Financial Designs increased its Global X Genomics & Biotechnology ETF (GNOM) stake by 13% in Q2 2026, buying an estimated $63.5K and bringing the position to 11,892 shares worth $676K. The position accounts for 0.03% of the portfolio, ranked #345.

Creative Financial Designs first reported a position in GNOM in Q3 2021 and has held it in 18 quarters since. 48 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

  • Creative Financial Designs held 11,892 shares of Global X Genomics & Biotechnology ETF worth $676K as of Q2 2026.
  • Creative Financial Designs bought 1,332 Global X Genomics & Biotechnology ETF shares in Q2 2026, an estimated $63.5K.
  • Global X Genomics & Biotechnology ETF made up 0.03% of Creative Financial Designs's portfolio in Q2 2026, its #345 holding.
  • Creative Financial Designs first reported a position in Global X Genomics & Biotechnology ETF in Q3 2021 and has held it in 18 quarters since.
  • 48 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.